摘要
目的分析前列地尔治疗高龄糖尿病并慢性肾脏病的临床效果。方法选择该院2014年4月—2015年9月间收治的87例高龄糖尿病并慢性肾脏病患者为观察对象,随机将其分成两组,对照组(n=44)采用一般治疗,实验组(n=43)加用前列地尔,观察两组治疗效果。结果对照组临床疗效(77.27%)明显低于实验组(93.02%),且两组各项指标(血尿素氮、血肌酐、24 h尿蛋白)存在差异(P<0.05);但两组患者治疗后不良反应发生率相比差异无统计学意义(P>0.05)。结论采用前列地尔治疗高龄糖尿病并慢性肾脏病的效果显著,安全可靠,值得推广。
Objective Analysis of clinical effect of alprostadil in the treatment of senile diabetes and chronic kidney dis- ease.Methods As the object of observation （September April 2014 to 2015 years） who were treated in our hospital were 87 cases of senile diabetes and chronic kidney disease patients were divided into two groups, control group（n= 44） with conven- tional therapy, the experimental group （n = 43） and alprostadil, observe the treatment effect of the two groups.Results The control group, the clinical efficacy （77.27%） was significantly lower in the experimental group （93.02%）, and two groups of indicators （blood urea nitrogen, blood creatinine, 24 hours proteinuria） exist difference（P〈0.05）; but after treatment in two groups of patients with adverse reactions occurred compared to the rate（P〉0.05）. Conclusion The use of alprostadil in treatment of elderly patients with diabetes and chronic kidney disease effect is remarkable, safe and reliable, worthy of promotion.
出处
《糖尿病新世界》
2016年第7期33-34,共2页
Diabetes New World Magazine
关键词
前列地尔
高龄
糖尿病
慢性肾脏病
Alprostadil
Elderly
Diabetes
Chronic kidney disease
